SEC Form 4 · accession 0001209191-16-138160
Arcadia Biosciences, Inc. · RKDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Uday Garg
Director · 10% Owner
Period of report
Aug 18, 2016
Accepted (ET)
Aug 22, 2016 · 5:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001469443
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.14 | Aug 18, 2016 | A | 18,112 | A | — | Aug 17, 2026 | Common Stock | 18,112 | 18,112 | D |
Explanation of responses
- F1The option will become 100% vested and exercisable on the earlier to occur of (i) August 18, 2017 or (ii) the date of the Issuer's next Annual Meeting of Stockholders.